Motley Fool Premium
  1. Stocks
    2. /
  2. Pfizer (NYSE: PFE)
    3. /

NYSE:PFE (Pfizer)

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Pfizer (NYSE: PFE) Latest News

    Investing

    Air Canada (TSX:AC) Stock Is Lifting off Despite a Gloomy Q3

    | Stephanie Bedard-Chateauneuf, MBA

    Air Canada (TSX:AC) soared on Monday despite posting a huge loss as Pfizer revealed its Covid-19 vaccine is 90% effective.

    Read more »

    Stocks for Beginners

    Coronavirus Vaccine: What TSX Investors Need to Know

    | Daniel Da Costa

    This morning, markets around the world are rallying on very promising news of a coronavirus vaccine. Here's which Canadian stocks…

    Read more »

    Investing

    Will Pfizer Inc. Look to Buy Valeant Pharmaceuticals Intl Inc.?

    | Jacob Donnelly

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is the right size for Pfizer Inc. (NYSE:PFE), but Valeant might actually turn out to…

    Read more »

    The Motley Fool
    Investing

    Billionaire Prem Watsa’s Top 3 Dividend Stocks

    | Robert Baillieul

    "Canada's Warren Buffett" owns these stocks. Should you?

    Read more »

    The Motley Fool
    Investing

    Why Did Valeant’s Shares Plunge Yesterday?

    | Benjamin Sinclair

    Jim Grant is "confidently bearish" on the company. Will his bet pay off?

    Read more »

    The Motley Fool
    Investing

    This Stock Just Keeps on Rolling

    | Benjamin Sinclair

    But with such a reliance on acquisitions, how long can the good times last?

    Read more »